WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2023)
Top medical stocks in 2023 ranked by overall Zen Score. See the best medical stocks to buy now, according to analyst forecasts for the medical instruments & supplies industry.

Industry: Medical Instruments & Sup...
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Top Analysts Upside/Downside
Consensus
Top Analysts Consensus
Analysts
Top Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
OSUR
ORASURE TECHNOLOGIES INC
$541.58M$7.37$5.00-32.16%Hold1-23.88%N/AN/AN/A
STAA
STAAR SURGICAL CO
$1.50B$30.80$47.7154.92%Buy711.69%83.96%N/AN/A
LMAT
LEMAITRE VASCULAR INC
$1.20B$54.01$67.6025.16%Buy56.67%9.39%12.57%10.86%
UTMD
UTAH MEDICAL PRODUCTS INC
$296.64M$81.73N/AN/AN/AN/AN/AN/AN/AN/A
MMSI
MERIT MEDICAL SYSTEMS INC
$3.78B$65.53$84.7529.33%Buy43.62%33.91%N/AN/A
PDEX
PRO DEX INC
$56.92M$16.05N/AN/AN/AN/AN/AN/AN/AN/A
RGEN
REPLIGEN CORP
$8.63B$154.55$188.7522.13%Strong Buy81.78%43.37%13.62%10.77%
WST
WEST PHARMACEUTICAL SERVICES INC
$25.41B$343.47$411.6719.86%Strong Buy36.14%18.07%N/AN/A
RMD
RESMED INC
$23.67B$160.95$193.2520.07%Strong Buy86.63%16.20%N/AN/A
HAE
HAEMONETICS CORP
$4.17B$82.09$99.5021.21%Buy23.70%19.05%24.42%10.85%
TFX
TELEFLEX INC
$10.69B$227.56$250.009.86%Buy73.37%26.28%N/AN/A
HOLX
HOLOGIC INC
$16.62B$69.26$83.2520.20%Buy83.21%61.27%N/AN/A
BDX
BECTON DICKINSON & CO
$67.84B$233.60$286.3322.57%Strong Buy65.09%85.03%N/AN/A
ATRC
ATRICURE INC
$1.65B$34.80$53.7554.45%Strong Buy411.03%N/AN/AN/A
ATR
APTARGROUP INC
$8.29B$125.99$152.0020.64%Strong Buy13.56%6.62%N/AN/A
ATRI
ATRION CORP
$546.97M$310.81N/AN/AN/AN/AN/AN/AN/AN/A
BNGO
BIONANO GENOMICS INC
$64.09M$1.65$10.00506.06%Strong Buy165.46%N/AN/AN/A
NEPH
NEPHROS INC
$22.33M$2.13N/AN/AN/AN/AN/AN/A-23.11%-18.24%
ANGO
ANGIODYNAMICS INC
$264.18M$6.63$16.33146.35%Strong Buy33.84%27.29%N/AN/A
EKSO
EKSO BIONICS HOLDINGS INC
$23.63M$1.66N/AN/AN/AN/A20.06%N/AN/AN/A
NYXH
NYXOAH SA
$137.58M$4.80$11.50139.58%Strong Buy4122.92%N/AN/AN/A
ISRG
INTUITIVE SURGICAL INC
$108.97B$309.52$354.6214.57%Strong Buy1310.12%9.17%N/AN/A
SMTI
SANARA MEDTECH INC
$283.48M$33.20$54.0062.65%Strong Buy2N/AN/A2.12%1.24%
NVST
ENVISTA HOLDINGS CORP
$4.06B$23.70$34.0043.46%Strong Buy62.29%32.39%N/AN/A
AKYA
AKOYA BIOSCIENCES INC
$225.26M$4.59$8.0074.29%Strong Buy414.64%N/AN/AN/A
EMBC
EMBECTA CORP
$1.04B$18.06$16.00-11.41%Strong Sell1-0.65%46.23%N/AN/A
BAX
BAXTER INTERNATIONAL INC
$18.16B$35.80$46.4329.69%Buy71.87%0.05%N/AN/A
ALC
ALCON INC
$35.55B$72.08$86.7620.36%Buy73.36%89.03%9.45%6.48%
ICUI
ICU MEDICAL INC
$2.15B$88.91N/AN/AN/AN/A-1.95%N/A11.53%5.53%
KRMD
KORU MEDICAL SYSTEMS INC
$105.50M$2.31$3.8365.93%Strong Buy37.66%N/AN/AN/A
PLSE
PULSE BIOSCIENCES INC
$516.92M$9.40N/AN/AN/AN/AN/AN/AN/AN/A
HBIO
HARVARD BIOSCIENCE INC
$197.22M$4.62$7.0051.52%Buy14.38%N/AN/AN/A
POAI
PREDICTIVE ONCOLOGY INC
$13.39M$3.30N/AN/AN/AN/AN/AN/AN/AN/A
BLFS
BIOLIFE SOLUTIONS INC
$584.74M$13.28$25.5092.02%Strong Buy4-6.19%N/AN/AN/A
FEMY
FEMASYS INC
$19.85M$0.92$9.00881.46%Strong Buy3132.69%N/AN/AN/A
OMIC
SINGULAR GENOMICS SYSTEMS INC
$28.99M$0.40$1.00153.16%Hold1-3.66%N/A-45.72%-31.98%
POCI
PRECISION OPTICS CORPORATION INC
$37.25M$6.14N/AN/AN/AN/AN/AN/AN/AN/A
WRBY
WARBY PARKER INC
$1.29B$10.95$15.8344.59%Buy68.77%N/AN/AN/A
COO
COOPER COMPANIES INC
$16.60B$335.29$402.8620.15%Strong Buy76.85%53.76%N/AN/A
AVGR
AVINGER INC
$4.40M$3.21$5.0055.76%Buy121.67%N/AN/AN/A
AZTA
AZENTA INC
$3.94B$56.95$61.507.99%Buy25.91%N/AN/AN/A
STVN
STEVANATO GROUP SPA
$7.45B$25.21$33.5733.17%Strong Buy77.95%2.04%N/AN/A
NXGL
NEXGEL INC
$11.95M$2.09N/AN/AN/AN/AN/AN/AN/AN/A
XRAY
DENTSPLY SIRONA INC
$6.82B$32.18$37.0014.98%Buy61.36%N/AN/AN/A
INFU
INFUSYSTEM HOLDINGS INC
$225.60M$10.65N/AN/AN/AN/AN/AN/AN/AN/A
LUCY
INNOVATIVE EYEWEAR INC
$6.07M$0.47$1.75272.34%Strong Buy1N/AN/AN/AN/A
STSS
SHARPS TECHNOLOGY INC
$7.26M$0.48N/AN/AN/AN/AN/AN/AN/AN/A
MHUA
MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD
$38.30M$1.60N/AN/AN/AN/AN/AN/AN/AN/A
GCTK
GLUCOTRACK INC
$6.48M$0.31N/AN/AN/AN/AN/AN/AN/AN/A
STXS
STEREOTAXIS INC
$150.45M$1.86N/AN/AN/AN/AN/AN/AN/AN/A
BLCO
BAUSCH & LOMB CORP
$5.30B$15.12$20.4335.11%Buy75.89%N/A7.98%4.16%
NSTG
NANOSTRING TECHNOLOGIES INC
$26.42M$0.55$2.83415.48%Buy513.01%N/AN/AN/A
MBOT
MICROBOT MEDICAL INC
$14.28M$1.22$8.00555.74%Buy1N/AN/A-243.44%-201.53%
MLSS
MILESTONE SCIENTIFIC INC
$57.19M$0.81N/AN/AN/AN/AN/AN/AN/AN/A
RVP
RETRACTABLE TECHNOLOGIES INC
$32.93M$1.10N/AN/AN/AN/AN/AN/AN/AN/A
ZTEK
ZENTEK LTD
$121.06M$1.20N/AN/AN/AN/AN/AN/AN/AN/A
ZJYL
JIN MEDICAL INTERNATIONAL LTD
$196.80M$24.60N/AN/AN/AN/AN/AN/AN/AN/A

Medical Stocks FAQ

What are the best medical stocks to buy right now in Dec 2023?

According to Zen Score, the 3 best medical stocks to buy right now are:

1. Staar Surgical Co (NASDAQ:STAA)


Staar Surgical Co (NASDAQ:STAA) is the top medical stock with a Zen Score of 58, which is 26 points higher than the medical industry average of 32. It passed 19 out of 33 due diligence checks and has strong fundamentals. Staar Surgical Co has seen its stock lose -50.59% over the past year, underperforming other medical stocks by -38 percentage points.

Staar Surgical Co has an average 1 year price target of $47.71, an upside of 54.92% from Staar Surgical Co's current stock price of $30.80.

Staar Surgical Co stock has a consensus Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Staar Surgical Co, 28.57% have issued a Strong Buy rating, 14.29% have issued a Buy, 57.14% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Orasure Technologies (NASDAQ:OSUR)


Orasure Technologies (NASDAQ:OSUR) is the second best medical stock with a Zen Score of 58, which is 26 points higher than the medical industry average of 32. It passed 18 out of 33 due diligence checks and has strong fundamentals. Orasure Technologies has seen its stock return 45.65% over the past year, overperforming other medical stocks by 59 percentage points.

Orasure Technologies has an average 1 year price target of $5.00, a downside of -32.16% from Orasure Technologies's current stock price of $7.37.

Orasure Technologies stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Orasure Technologies, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Lemaitre Vascular (NASDAQ:LMAT)


Lemaitre Vascular (NASDAQ:LMAT) is the third best medical stock with a Zen Score of 53, which is 21 points higher than the medical industry average of 32. It passed 20 out of 38 due diligence checks and has strong fundamentals. Lemaitre Vascular has seen its stock return 17.39% over the past year, overperforming other medical stocks by 30 percentage points.

Lemaitre Vascular has an average 1 year price target of $67.60, an upside of 25.16% from Lemaitre Vascular's current stock price of $54.01.

Lemaitre Vascular stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Lemaitre Vascular, 20% have issued a Strong Buy rating, 60% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the medical stocks with highest dividends?

Out of 11 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

1. Baxter International (NYSE:BAX)


Baxter International (NYSE:BAX) has an annual dividend yield of 3.24%, which is 2 percentage points higher than the medical industry average of 1.32%. Baxter International's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Baxter International's dividend has not shown consistent growth over the last 10 years.

Baxter International's dividend payout ratio of 22.6% indicates that its dividend yield is sustainable for the long-term.

2. Atrion (NASDAQ:ATRI)


Atrion (NASDAQ:ATRI) has an annual dividend yield of 2.8%, which is 1 percentage points higher than the medical industry average of 1.32%. Atrion's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Atrion's dividend has shown consistent growth over the last 10 years.

Atrion's dividend payout ratio of 71.6% indicates that its dividend yield is sustainable for the long-term.

3. Dentsply Sirona (NASDAQ:XRAY)


Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 1.69%, which is the same as the medical industry average of 1.32%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -54.5% indicates that its dividend yield might not be sustainable for the long-term.

Why are medical stocks down?

Medical stocks were down -2.03% in the last day, and up 0.47% over the last week. Merit Medical Systems was the among the top losers in the medical instruments & supplies industry, dropping -11.37% yesterday.

Merit Medical shares are trading lower after the company announced a proposed private placement of $550 million of convertible senior notes.

What are the most undervalued medical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued medical stocks right now are:

1. Orasure Technologies (NASDAQ:OSUR)


Orasure Technologies (NASDAQ:OSUR) is the most undervalued medical stock based on WallStreetZen's Valuation Score. Orasure Technologies has a valuation score of 86, which is 57 points higher than the medical industry average of 29. It passed 6 out of 7 valuation due diligence checks.

Orasure Technologies's stock has gained 45.65% in the past year. It has overperformed other stocks in the medical industry by 59 percentage points.

2. Pro Dex (NASDAQ:PDEX)


Pro Dex (NASDAQ:PDEX) is the second most undervalued medical stock based on WallStreetZen's Valuation Score. Pro Dex has a valuation score of 86, which is 57 points higher than the medical industry average of 29. It passed 6 out of 7 valuation due diligence checks.

Pro Dex's stock has dropped -5.06% in the past year. It has overperformed other stocks in the medical industry by 8 percentage points.

3. Embecta (NASDAQ:EMBC)


Embecta (NASDAQ:EMBC) is the third most undervalued medical stock based on WallStreetZen's Valuation Score. Embecta has a valuation score of 86, which is 57 points higher than the medical industry average of 29. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -46.62% in the past year. It has underperformed other stocks in the medical industry by -34 percentage points.

Are medical stocks a good buy now?

50% of medical stocks rated by analysts are a strong buy right now. On average, analysts expect medical stocks to rise by 22.81% over the next year.

What is the average p/e ratio of the medical instruments & supplies industry?

The average P/E ratio of the medical instruments & supplies industry is 45.7x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.